CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 200 filers reported holding CHEMOCENTRYX INC in Q4 2020. The put-call ratio across all filers is 1.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $9,293,000 | -9.4% | 181,365 | +9.5% | 0.01% | -12.5% |
| Q4 2020 | $10,257,000 | +10.8% | 165,656 | -2.0% | 0.01% | 0.0% |
| Q3 2020 | $9,259,000 | +11.7% | 168,956 | +17.3% | 0.01% | 0.0% |
| Q2 2020 | $8,288,000 | +75.5% | 144,036 | +22.5% | 0.01% | +33.3% |
| Q1 2020 | $4,723,000 | +3.8% | 117,543 | +2.1% | 0.01% | +50.0% |
| Q4 2019 | $4,552,000 | +534.0% | 115,098 | +75.0% | 0.00% | +300.0% |
| Q4 2018 | $718,000 | -66.4% | 65,787 | -61.1% | 0.00% | -50.0% |
| Q3 2018 | $2,137,000 | -1.0% | 169,037 | +3.2% | 0.00% | 0.0% |
| Q2 2018 | $2,158,000 | +407.8% | 163,871 | +423.9% | 0.00% | – |
| Q1 2018 | $425,000 | +59.2% | 31,279 | -13.1% | 0.00% | – |
| Q3 2017 | $267,000 | -31.2% | 35,991 | -13.2% | 0.00% | – |
| Q2 2017 | $388,000 | +30.6% | 41,442 | +1.7% | 0.00% | – |
| Q1 2017 | $297,000 | – | 40,744 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |